The Peter Attia Drive

View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter's Weekly Newsletter
In this "Ask Me Anything" (AMA) episode, Peter explores what laboratory testing can—and cannot—tell us about our health. Blood tests provide objective numbers and reference ranges, making them an appealing way to assess overall health. But their usefulness is far more nuanced than it may appear. Peter begins by explaining how to interpret lab results in the context of both lifespan and healthspan, emphasizing the importance of tracking changes over time rather than relying on isolated measurements. He then examines the strengths and limitations of blood testing for assessing risk across the major chronic diseases, including cardiovascular disease, metabolic dysfunction, cancer, and neurodegenerative disease. He explains what labs can reveal about organ health and where additional information from imaging, body composition, and functional testing is needed. The conversation also explores why more testing does not necessarily lead to better clinical decisions. Peter discusses the limitations of large direct-to-consumer testing panels and sophisticated measures such as lipid subfractionation and biological-age scores, particularly when the results lack clear clinical actionability. He also highlights the importance of physical function, cognitive performance, and emotional health—critical components of healthspan that cannot be adequately captured through blood work alone. Finally, Peter provides a practical framework for evaluating any laboratory test, understanding its limitations, and determining whether the results offer meaningful information that can guide decisions about health and longevity.
If you're not a subscriber and are listening on a podcast player, you'll only be able to hear a preview of the AMA. If you're a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #91 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.
We discuss:
Why lab testing is insufficient to answer the question "Am I healthy?" [2:15];
Defining health through the lenses of lifespan, health span, and fundamental organ systems, and how labs can come up short [5:45];
The importance of longitudinal data, and the strengths and blind spots of labs for assessing cardiovascular disease risk [10:00];
Using labs to assess metabolic health, and the additional insights from body composition, behavior, and functional testing [18:45];
What blood tests and genetic testing can reveal about cancer detection and future cancer risk [23:00];
Assessing neurodegenerative disease risk through genetics, cardiometabolic markers, and emerging blood-based biomarkers [28:00];
What routine labs reveal about organ systems, and how to evaluate large direct-to-consumer testing panels [35:00];
Sophisticated tests that lack clinical actionability: lipid subfractionation, biological-age scores, and sleep scores [41:30];
Why labs provide limited insight into physical function, cognitive function, and emotional health [47:30];
A practical framework for interpreting any lab test, understanding its blind spots, and placing results in context [53:30]; and
More.
Connect With Peter on Twitter, Instagram, Facebook and YouTube

View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter's Weekly Newsletter
In this episode, Peter welcomes back Jeff Cavaliere, a physical therapist, strength coach, and founder of ATHLEAN-X who has spent decades bridging the gap between rehabilitation, athletic performance, and strength training. Jeff begins by sharing how his experience working with professional athletes and managing his own injuries has shaped his approach to building strength and muscle while minimizing injury risk. He discusses how training should evolve as we age, particularly for those in their 40s, 50s, and beyond who want to continue making progress without compromising long-term joint health. Jeff explains why excessive training volume can be counterproductive and how to balance reps in reserve with training to failure to maximize results while managing fatigue and injury risk. He also explores the differences between training for aesthetics and functional performance, explaining why these goals are not necessarily at odds. The conversation then shifts to a muscle-by-muscle breakdown of effective exercises for building strength and hypertrophy. Jeff highlights common training mistakes, offers modifications for those dealing with pain or injury, and explains why often-neglected muscles deserve more attention. Finally, he walks through his "exercise graveyard," identifying popular exercises that may carry unnecessary injury risk and offering alternatives that deliver similar benefits with less risk. Throughout the episode, Jeff provides actionable guidance for making training more effective, sustainable, and adaptable as we age.
We discuss:
Jeff's passion as an educator and the path that led him to build his YouTube channel [2:30];
Jeff's injury history and how he overcomes injury in training [11:00];
Qualities of great athletes and the tragedy of injury [20:15];
Tom Brady—an example of the value of pliability and consistency [24:30];
The athlete's mindset, how training changes in midlife, and the importance of a warm-up [28:15];
Reducing risk of injury in middle age and beyond: reps in reserve, training to failure, and junk volume [35:15];
How training intensity changes in midlife [44:30];
Hypertrophy: misconceptions and common mistakes when training shoulders [48:15];
Deltoid muscles of the shoulder: exercises beyond the overhead press [59:45];
Triceps: compound movements and exercises that target the long head [1:11:15];
Upper arm: best approaches for building hypertrophy and strength [1:21:00];
Biceps: nuance around training [1:24:30];
Forearm exercises that target the flexors and brachioradialis [1:31:45];
Pecs and chest: pressing and crossover movements [1:34:15];
Great abs: nutrition, rotation exercises, interval training, and more [1:45:30];
Back: exercises to create that V-shape [1:52:30];
Legs: training the quads, glutes, and more [2:02:00];
Calves: training the gastrocnemius and soleus [2:13:00];
Jeff's "exercise graveyard" and recommendations for modifications that achieve results with less risk of injury [2:21:00]; and
More.
Connect With Peter on Twitter, Instagram, Facebook and YouTube

View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter's Weekly Newsletter
In this episode, Peter sits down with Dr. Lisa Feldman Barrett, a psychologist, neuroscientist, author, and distinguished professor at Northeastern University whose research challenges many of the conventional assumptions about emotions and how the brain works. Lisa is best known for her theory of constructed emotion, which challenges the idea that emotions such as fear, anger, and sadness are hardwired responses with universal biological signatures. She begins by explaining how unexpected findings early in her research led her to question traditional theories of emotion. She discusses why studying individual variation, rather than relying on averages, is essential to understanding the brain. Lisa then explores the idea that the brain is fundamentally a predictive system rather than a reactive one. She explains how past experiences and memories shape what we perceive, feel, and do. She also describes how the brain continuously anticipates and regulates metabolism through a process called allostasis. The conversation then turns to the effects of chronic stress, uncertainty, and childhood adversity on physical and emotional health. Lisa explains how our relationships help regulate our nervous systems and why the loss of a loved one can have such a profound physiological impact. She also discusses how deliberate practice and new experiences can reshape the brain's predictions, potentially changing how we think, feel, and respond to the world around us. Throughout the discussion, Peter and Lisa explore how this framework challenges traditional views of emotion and offers a greater sense of agency over our emotional lives.
We discuss:
How unexpected results in graduate school changed Lisa's understanding of emotion [3:30];
Why variation is the norm for emotion, and the danger in tracking averages instead of characterizing variation [15:30];
Lisa's experience with Hashimoto's disease and the value of modeling individual variation [30:00];
How Lisa's research challenges common views about emotions, and why there is no biomarker for emotions [40:00];
The difficulty of defining emotions and the brain's role in regulating the body [49:15];
Consciousness, interoception, and the limits of subjective experience [54:00];
Defining emotion: fear and anger [1:00:15];
The brain as a predictive system rather than a reactive one [1:13:15];
Baseball as an example of the brain's predictive nature [1:31:00];
How the human brain differs from that of other animals [1:44:00];
The impact of stress on metabolism, and the role of the brain in maintaining allostasis [1:49:45];
Childhood adversity, social regulation of the nervous system, and the effect of chronic stress [1:56:45];
Understanding chronic stress: why some people respond differently, and its impact on metabolism [2:02:15];
How practicing new predictions can change thoughts and feelings [2:10:15];
Lisa's practice of finding awe in everyday experiences and the greater sense of agency it brings [2:13:30];
The impact of grief on nervous system regulation and the metabolic "body budget," as well as practices that reduce sadness [2:22:15];
The connection between memories and predictions, and Peter's closing thoughts [2:29:45]; and
More.
Connect With Peter on Twitter, Instagram, Facebook and YouTube

View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter's Weekly Newsletter
In this episode, Peter welcomes back Dr. Siddhartha Mukherjee, a physician, oncologist, researcher, and the Pulitzer Prize-winning author of The Emperor of All Maladies. Fifteen years after the book was first published, Sid released an updated edition. This conversation examines what has changed in our understanding of cancer—not only in how we treat it, but in how we think about its causes, prevention, detection, and biology. Sid explores the contributions of genetics, environmental exposures, random mutations, and inflammation to cancer risk, including the emerging role of hyperinsulinemia and metabolism. He discusses why detecting cancer early remains so difficult, particularly in pancreatic cancer, and how advances in immunotherapy, CAR T cell therapy, and targeted treatments such as KRAS inhibitors are changing the treatment landscape. The conversation then broadens beyond cancer to what Sid calls "regenerative failure"—the declining ability of tissues to repair and replenish themselves with age. Peter and Sid explore how this process may contribute to conditions such as osteoarthritis, and whether longevity should be approached less as the prevention of individual diseases and more as the preservation of regenerative capacity. Sid weighs in on the potential for chemoprevention, metabolic interventions, and AI to transform cancer prevention and treatment. Finally, they discuss what it would take to develop meaningful biomarkers of longevity that could ultimately help to extend human healthspan and lifespan.
We discuss:
What oncology has learned in the 15 years since The Emperor of All Maladies was published [2:45];
The contributions of genetic risk, bad luck, and inflammation to cancer [14:45];
The role of metabolism and hyperinsulinemia in cancer [31:00];
Osteoarthritis: the role of inflammation and regenerative stem cells [40:45];
How cancer escapes the immune system—the subtleties of neoantigens and immune checkpoints [49:45];
AI and the thymus as a predictor of longevity, and T cell aging and immune regeneration [57:15];
How CAR T cell therapy works and why solid tumors are harder to treat [1:04:00];
Targeting KRAS in pancreatic cancer [1:10:45];
The rise of colorectal cancer in younger adults [1:19:15];
How AI may transform drug discovery [1:23:00];
The future of cancer prevention: chemoprevention [1:33:15];
Challenging the current model of longevity—disease prevention versus targeting regenerative failure [1:37:45];
The need for a biomarker of longevity—comparing geroscience to atherosclerosis [1:50:30];
Clinical trials targeting cancer metabolism [1:56:00];
What Sid is currently writing about and a glimpse into his writing process [1:58:00]; and
More.
Connect With Peter on Twitter, Instagram, Facebook and YouTube

View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter's Weekly Newsletter
In this "Ask Me Anything" (AMA) episode, Peter looks back on 400 episodes of The Drive with another installment of "strong convictions, loosely held," revisiting some of the positions he has taken over more than eight years of the podcast. He explains why changing one's mind in response to new evidence, conversations with experts, and clinical experience is essential for practicing medicine well. Peter begins with nutrition, describing how his views on ketogenic diets, extended fasting, and the framework of dietary restriction, time restriction, and calorie restriction have evolved. He explains why he no longer takes metformin for longevity and discusses his growing uncertainty around rapamycin despite compelling animal data. Peter also revisits his views on cancer screening, including whole-body MRI and liquid biopsies for early detection. On exercise, Peter explains how his approach to cardiorespiratory training and the 80/20 Zone 2 framework has changed, particularly for people with limited time to train. He also shares why he has moved away from heavy barbell squats and deadlifts and how he now thinks about balancing benefit and injury risk. Throughout the episode, Peter emphasizes the importance of focusing on durable principles, strong foundations, and sustainable practices rather than chasing optimizations that provide marginal gains.
If you're not a subscriber and are listening on a podcast player, you'll only be able to hear a preview of the AMA. If you're a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #90 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.
We discuss:
Strong convictions, loosely held: changing opinions as evidence, expert conversations, and clinical experience evolve [2:00];
Nutrition: Peter's evolving view of ketogenic diets, energy balance, and dietary dogmatism [5:30];
Extended fasting, autophagy, lean-mass loss, and who may benefit from prolonged fasting [12:00];
The dietary restriction, time restriction, and calorie restriction framework—and why GLP-1 agonists are tipping the balance toward calorie restriction [20:15];
Why Peter no longer views metformin as geroprotective for metabolically healthy people [24:45];
Rapamycin for longevity: compelling animal data, unresolved human dosing, and Peter's growing uncertainty [29:15];
The importance of early cancer detection, declining whole-body magnetic resonance imaging (MRI) quality, and more targeted alternatives [41:30];
Liquid biopsies for cancer screening: the NHS-Galleri trial, why early-stage rather than late-stage detection is what actually matters, and why the technology remains "fuzzy" [53:30];
Evolving exercise goals, the limitations of the 80/20 Zone 2 framework, and programming cardio at lower training volumes [1:00:00];
Exercise prescriptions for limited time, building a training habit, and becoming less dogmatic about forcing workouts [1:05:00];
Moving away from heavy squats and deadlifts, alternative exercises, and deliberate risk management [1:13:00];
Prioritizing principles, foundations, and sustainable practices over marginal optimization [1:21:30]; and
More.
Connect With Peter on Twitter, Instagram, Facebook and YouTube